DOI: https://doi.org/10.29296/24999490-2019-04-07

N.V. Maltseva(1), T.A. Laputenko(2), A.Sh. Smirnova(1), S.L. Kan(1) 1-Novokuznetsk State Institute for Further Training of Physicians – Branch Campus of the Federal State Budgetary Educational Institution of Further Professional Education «Russian Medical Academy of Continuous Professional Education» of the Ministry of Healthcare of the Russian Federation, Stroiteley 5, Novokuznetsk 654005, Russian Federation; 2-LLC «Grand Medica», Kuznetskstroyevsky avenue 11, Novokuznetsk, 654007, Russian Federation E-mail: ninamaltseva2015@mail.ru

Introduction. The genetically determined tendency of patients to thrombosis may be one of the etiopathophysiological factors of the infective endocarditis (IE). Aim. А search for variants of genes and their combinations in the hemostatic system, the carriage of which affects the pathogenesis (risks and outcome) of IE. Material and methods. Genotyping of 66 IE patients (20 women and 46 men), including 33 men and 12 women with acute and 13 men and 8 women with subacute course of the disease, and 63 patients (30 women and 33 men) with sepsis on polymorphic loci rs1801133 methylenetetrahydrofolate reductase gene MTHFR (MTHFRAla222Val(C677T)), rs1800790 of the beta-fibrinogen gene FGB (FGB-455G-A), rs5918 of the beta-3 integrin, thrombocyte fibrinogen receptor gene ITGB3 (ITGB3Leu33Pro(T1565C)) was carried out by the allele-specific polymerase chain reaction method. Results. Monogenic and combined carriage of MTHFR222Val(677T), FGB-455-A, ITGB3Leu33(T1565) alleles is associated with an increased risk of the development and death in IE cases. Conclusion. Multiplex analysis of variants of the polymorphic loci of the hemostatic system genes should be included in the algorithm of genotyping in the diagnosis and treatment of IE patients.
infective endocarditis, sepsis, gene, single-nucleotide polymorphism, hemostasis, pathogenesis

Список литературы: 
  1. Данилов А.И., Алексеева И.В., Аснер Т.В., Власова Е.Е., Данилова Е.М., Дехнич А.В. и др. Этиология инфекционного эндокардита в России. Клиническая Микробиология и Антимикробная Химиотерапия. 2015; 17 (1): 4–10. http://www.antibiotic.ru/cmac/2015/n1.shtml
  2. [Danilov A.I., Alekseeva I.V., Asner T.V., Vlasova E.E., Danilova E.M., Dekhnich A.V. et al. Etiology of Infective Endocarditis in Russia. Klinicheskaya Microbiologiya i Antimicrobnaya Chimiotherapiya. 2015; 17 (1): 4–10 (in Russian)]
  3. Виноградова Т.Л. Инфекционный эндокардит: современное течение. Клиницист. 2011; 3: 4–9. http://dx.doi.org/10.17650/1818-8338-2011-3-4-9 [Vinogradova T.L. Infekcionnyj jendokardit: sovremennoe techenie. Klinicist. 2011; 3: 4–9 (in Russian)]
  4. Руководство по кардиологии: Учебное пособие в 3 т. Под ред. Г.И. Сторожакова, А.А. Горбаченкова. М.: ГЭОТАР-Медиа, 2008; 1: 672. [Rukovodstvo po kardiologii : Uchebnoe posobie v 3 t. Pod red. G.I. Storozhakova, A.A. Gorbachenkova. M.: GJeOTAR-Media, 2008; 1: 672 (in Russian)]
  5. Keane C., Petersen H., Reynolds K., Newman D.K., Cox D., Jenkinson H.F., Newman P.J., Kerrigan S.W. Mechanism of Outside-In αIIbβ3-Mediated Activation of Human Platelets by the Colonizing Bacterium, Streptococcus gordonii. Arteriosclerosis, Thrombosis and Vascular Biology. https://doi.org/10.1161/ATVBAHA.110.216515 2010;30:2408-2415
  6. Мальцева Н.В., Лапутенко Т.А., Смирнова А.Ш., Горбатовский Я.А. Способ ранней диагностики острого инфекционного эндокардита. Патент РФ; №2651769; 2018: Бюл. №12. [Mal’tseva N.V., Laputenko T.A., Smirnova A.Sh., Gorbatovskii Ya.A. The method of early diagnosis of acute infective endocarditis. Patent RF; №2651769; 2018: Bull. №12 (in Russian)]
  7. Мальцева Н.В., Лапутенко Т.А., Смирнова А.Ш., Горбатовский Я.А., Никифоров В.В., Дадыка И.В. -455А аллель гена FGB в дифференциальной диагностике острого инфекционного эндокардита и сепсиса. Клиническая медицина 2018; 96 (4): 321–7.
  8. [Mal’tseva N.V., Laputenko T.A., Smirnova A.Sh., Gorbatovskii Ya.A., Nikiforov V.V., Dаdyka I.V. -455А allele of FGB gene in differential diagnostics of acute infective endocarditide and sepsis. Klinicheskaja medicina. 2018; 96 (4): 321–7 (in Russian)]
  9. Демин А.А. Инфекционный эндокардит. В кн.: под ред. Е.В. Шляхто. Кардиология: национальное руководство. М.: ГЭОТАР-Медиа, 2015; 605–22. [Demin A.A Infective endocarditis. V kn.: pod red. E.V. SHlyahto. Kardiologiya: natsional’noe rukovodstvo. M.: GEOTAR-Media, 2015; 605–22 (in Russian)]
  10. Durante-Mangoni E., Molaro R., Iossa D. The role of hemostasis in infective endocarditis. Curr. Infect. Dis. Rep. 2014; 16 (11): 435. https://doi.org/10.1007/s11908-014-0435-8
  11. Bezgin T., Kaymaz C., Akbal Ö., Yilmaz F., Tokgöz H.C., Özdemir N. Thrombophilic Gene Mutations in Relation to Different Manifestations of Venous Thromboembolism: A Single Tertiary Center Study. Clin. Appl. Thromb. Hemost. 2016; 24 (1): 100–6. https://doi.org/10.1177/1076029616672585
  12. Green F.R. Fibrinogen polymorphisms and atherothrombotic disease. Ann. N. Y. Acad. Sci. 2001; 936: 549–59. https://doi.org/10.1111/j.1749-6632.2001.tb03543.x
  13. Komsa-Penkova R., Golemanov G., Tsankov B., Ivanov P., Beshev L., Tonchev P. Rs5918ITGB3 Polymorphism, Smoking, and BMI as Risk Factors for Early Onset and Recurrence of DVT in Young Women. Clin. Appl. Thromb. Hemost. 2017; 23 (6): 585–95. https://doi.org/10.1177/1076029615624778
  14. Daga S., Shepherd J.G., Callaghan J.G., Hung R.K., Dawson D.K., Padfield G.J., Hey S.Y., Cartwright R.A., Newby D.E., Fitzgerald J.R. Platelet receptor polymorphisms do not influence Staphylococcus aureus-platelet interactions or infective endocarditis. Microbes Infect. 2011; 13 (3): 216–25. https://doi.org/10.1016/j.micinf.2010.10.016
  15. Frosst P., Blom H. J., Milos R., Goyette P., Sheppard C. A., Matthews R. G., Boers G. J. H., den Heijer M., Kluijtmans L. A. J., van den Heuvel L. P., Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet. 1995; 10: 111–3.
  16. Klerk M., Verhoef P., Clarke R., Blom H. J., Kok F. J., Schouten E. G.; MTHFR Studies Collaboration Group. MTHFR 677C-T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA. 2002; 288 (16): 2023–31. https://doi.org/10.1001/jama.288.16.2023
  17. Newman P.J., Derbes R.S., Aster R.H. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J. Clin. Invest. 1989; 83: 1778–81. https://doi.org/10.1172/JCI114082
  18. Martinez C., Antón A.I., Corral J., Quiroga T., Panes O., Lozano M.L., González-Conejero R., Teruel R., Navarro-Núñez L., Pereira J., Mezzano D., Vicente V., Rivera J. Genotype-phenotype relationship for six common polymorphisms in genes affecting platelet function from 286 healthy subjects and 160 patients with mucocutaneous bleeding of unknown cause. Br. J. Haematol. 2009; 146 (1): 95–103. https://doi.org/10.1111/j.1365-2141.2009.07713.x
  19. Juan A. Iniesta, Rocio González-Conejero, Claudio Piqueras, Vicente Vicente, Javier Corral. Platelet GP IIIa Polymorphism HPA-1 (PlA) Protects Against Subarachnoid Hemorrhage. Stroke. 2004; 35: 2282–6. https://doi.org/10.1161/01.STR.0000141978.33388.eb
  20. Undas A., Brummel K., Musial J., Mann K.G., Szczeklik A. Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation. 2001; 104 (22): 2666–72. https://doi.org/10.1161/hc4701.099787